Short interest in NeuroSense Therapeutics Ltd (NASDAQ:NRSN) decreased during the last reporting period, falling from 290.56K to 200.11K. This put 0.99% of the company's publicly available shares short.

Short interest for NeuroSense Therapeutics gives investors a sense of the degree to which investors are betting on the decline of NeuroSense Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 665.29K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.